These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 28844812)
1. Antidepressant-like effects of 3-carboxamido seco-nalmefene (3CS-nalmefene), a novel opioid receptor modulator, in a rat IFN-α-induced depression model. Callaghan CK; Rouine J; Dean RL; Knapp BI; Bidlack JM; Deaver DR; O'Mara SM Brain Behav Immun; 2018 Jan; 67():152-162. PubMed ID: 28844812 [TBL] [Abstract][Full Text] [Related]
2. Exercise prevents IFN-α-induced mood and cognitive dysfunction and increases BDNF expression in the rat. Callaghan CK; Rouine J; O'Mara SM Physiol Behav; 2017 Oct; 179():377-383. PubMed ID: 28711394 [TBL] [Abstract][Full Text] [Related]
3. Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test. Makino M; Kitano Y; Komiyama C; Hirohashi M; Takasuna K Br J Pharmacol; 2000 Jul; 130(6):1269-74. PubMed ID: 10903965 [TBL] [Abstract][Full Text] [Related]
4. Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies. Zhang H; Shi YG; Woods JH; Watson SJ; Ko MC Eur J Pharmacol; 2007 Sep; 570(1-3):89-96. PubMed ID: 17601558 [TBL] [Abstract][Full Text] [Related]
5. Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through delta- and micro-opioid receptors independent of antidepressant-like effects. Zhang H; Torregrossa MM; Jutkiewicz EM; Shi YG; Rice KC; Woods JH; Watson SJ; Ko MC Eur J Neurosci; 2006 Feb; 23(4):984-94. PubMed ID: 16519663 [TBL] [Abstract][Full Text] [Related]
6. Chronic administration of buprenorphine in combination with samidorphan produces sustained effects in olfactory bulbectomised rats and Wistar-Kyoto rats. Burke NN; Li Y; Deaver DR; Finn DP; Roche M; Eyerman DJ; Sanchez C; Kelly JP J Psychopharmacol; 2019 Dec; 33(12):1620-1627. PubMed ID: 31512988 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Walker BM; Koob GF Neuropsychopharmacology; 2008 Feb; 33(3):643-52. PubMed ID: 17473837 [TBL] [Abstract][Full Text] [Related]
8. Crassifoside H improve the depressive-like behavior of rats under chronic unpredictable mild stress: Possible involved mechanisms. Zhang Y; Ge JF; Wang FF; Liu F; Shi C; Li N Brain Res Bull; 2017 Oct; 135():77-84. PubMed ID: 28970041 [TBL] [Abstract][Full Text] [Related]
9. Behavioral effects of the kappa opioid receptor partial agonist nalmefene in tests relevant to depression. Browne CA; Smith T; Lucki I Eur J Pharmacol; 2020 Apr; 872():172948. PubMed ID: 31991139 [TBL] [Abstract][Full Text] [Related]
10. Icariin reverses corticosterone-induced depression-like behavior, decrease in hippocampal brain-derived neurotrophic factor (BDNF) and metabolic network disturbances revealed by NMR-based metabonomics in rats. Gong MJ; Han B; Wang SM; Liang SW; Zou ZJ J Pharm Biomed Anal; 2016 May; 123():63-73. PubMed ID: 26874256 [TBL] [Abstract][Full Text] [Related]
11. Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity? Bart G; Schluger JH; Borg L; Ho A; Bidlack JM; Kreek MJ Neuropsychopharmacology; 2005 Dec; 30(12):2254-62. PubMed ID: 15988468 [TBL] [Abstract][Full Text] [Related]
12. Continuous delivery of naltrexone and nalmefene leads to tolerance in reducing alcohol drinking and to supersensitivity of brain opioid receptors. Korpi ER; Linden AM; Hytönen HR; Paasikoski N; Vashchinkina E; Dudek M; Herr DR; Hyytiä P Addict Biol; 2017 Jul; 22(4):1022-1035. PubMed ID: 26990998 [TBL] [Abstract][Full Text] [Related]
13. Behavioral changes after maternal separation are reversed by chronic constant light treatment. Dimatelis JJ; Stein DJ; Russell VA Brain Res; 2012 Oct; 1480():61-71. PubMed ID: 22975437 [TBL] [Abstract][Full Text] [Related]
14. Resveratrol ameliorates depressive-like behavior in repeated corticosterone-induced depression in mice. Ali SH; Madhana RM; K V A; Kasala ER; Bodduluru LN; Pitta S; Mahareddy JR; Lahkar M Steroids; 2015 Sep; 101():37-42. PubMed ID: 26048446 [TBL] [Abstract][Full Text] [Related]
16. Locomotor and anti-immobility effects of buprenorphine in combination with the opioid receptor modulator samidorphan in rats. Burke NN; Ferdousi M; Deaver DR; Finn DP; Roche M; Kelly JP Neuropharmacology; 2019 Mar; 146():327-336. PubMed ID: 30553825 [TBL] [Abstract][Full Text] [Related]